Signal transduction induced by opioids in immune cells: A review

NeuroImmunoModulation

Volumn 13, Issue 1, 2006, Pages 1-7

  Martin Kleiner, Irena ^a   Balog, Tihomir ^a   Gabrilovac, Jelka ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Mitogen activated protein kinase; Opioids; Second messenger

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CALCIUM; CYCLIC AMP; CYCLIC GMP; DELTA OPIATE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAPPA OPIATE RECEPTOR; KRUPPEL LIKE FACTOR 7; METENKEPHALIN; MITOGEN ACTIVATED PROTEIN KINASE; MU OPIATE RECEPTOR; NITRIC OXIDE; OPIATE; OPIATE AGONIST; OPIATE RECEPTOR; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN C FOS; RETINOIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR IKAROS 1; TRANSCRIPTION FACTOR IKAROS 2; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

CALCIUM CELL LEVEL; IMMUNOCOMPETENT CELL; NERVE CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANALGESICS, OPIOID; ANIMALS; HUMANS; LEUKOCYTES; MAP KINASE SIGNALING SYSTEM; NEUROIMMUNOMODULATION; RECEPTORS, OPIOID; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 33746820173     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092107     Document Type: Review

References (58)

1. Snyder SH, Pasternak GW: Historical review: opioid receptors. Trends Pharmacol Sci 2003;24:198-205.
2. Standifer KM, Pasternak GW: G proteins and opioid receptor-mediated signalling. Cell Signal 1997;9:237-248.
3. Sharp BM, Roy S, Bidlack JM: Evidence for opioid receptors on cells involved in host defense and the immune system. J Neuroimmunol 1998;83:45-56.
4. Bidlack JM: Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol 2000;7:719-723.
5. Sharp BM: Opioid receptor expression and function. J Neuroimmunol 2004;147:3-5.
6. Williams JT, Christie MJ, Manzoni O: Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 2001;81:299-343.
7. Zadina JE, Hackler L, Ge LJ, Kastin AJ: A potent and selective endogenous agonist for the μ-opiate receptor. Nature 1997;386:499-502.
8. Zhu W, Ma Y, Cadet P, Yu D, Bilfinger TV, Bianchi E, Stefano GB: Presence of reticuline in rat brain: a pathway for morphine biosynthesis. Brain Res Mol Brain Res 2003;117:83-90.
9. Chaturverdi K, Christoffers KH, Singh K, Howells RD: Structure and regulation of opioid receptors. Biopolymers 2000;55:334-346.
10. Meng F, Hoversten MT, Thompson RC, Taylor L, Watson SJ: A chimeric study of the molecular basis of affinity and selectivity of the kappa and delta opioid receptors. J Biol Chem 1995;270:12730-12736.
11. Chan AS, Law PY, Loh HH, Ho PNN, Wu WM, Chan JSC, Wong YH: The first and third intracellular loops together with the carboxy terminal tail of the delta-opioid receptor contribute toward functional interaction with the G alpha(16). J Neurochem 2003;87:697-708.
12. Zagon IS, Verderame MF, McLaughlin PJ: The biology of the opioid growth factor receptor (OGFr). Brain Res Rev 2002;38:351-376.
13. Tencheva ZS, Belcheva MM, Velichkova AA, Lissichkova EG, Coscia CJ: Opioid regulation of AP-1 DNA-binding activity in NG108-15 cells under conditions of opioid-receptor adaptation. Brain Res Mol Brain Res 1997;48:156-158.
14. Woltje M, Kraus J, Hollt V: Regulation of mouse delta-opioid receptor gene transcription: involvement of the transcription factors AP-1 and AP-2. J Neurochem 2000;74:1355-1362.
15. Hou YN, Vlaskovska M, Cebers G, Kasakov L, Liljequist S, Terenius L: A mu-opioid receptor opioid agonist induces AP-1 and NF-kappaB transcription factor activity in primary cultures of rat cortical neurons. Neurosci Lett 1996;212:159-162.
16. Tateyama S, Ikeda T, Kosai K, Nakamura T, Kasaba T, Takasaki M, Nishimori T: Endomorphins suppress nociception-induced c-Fos and Zif/268 expression in the rat spinal dorsal horns. Eur J Pharmacol 2002;451:79-87.
17. Bilecki W, Hollt V, Przewlocki R: Acute delta-opioid receptor activation induces CREB phosphorylation in NG108-15 cells. Eur J Pharmacol 2000;390:1-6.
18. Bilecki W, Wawrzczak-Bargiela A, Przewlocki R: Activation of AP-1 and CRE-dependent gene expression via mu-opioid receptor. J Neurochem 2004;90:874-882.
19. Law PY, Loh HH, Wei LN: Insight into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology 2004;47:300-301.
20. Pagliaro P: Differential biological effects of products of nitric oxide (NO) synthase: it is not enough to say NO. Life Sci 2003;73:2137-2149.
21. Kim MS, Cheong YP, So HS, Lee KM, Kim TY, Jaymin Oh, Chung YT, Son Y, Kim BR, Park R: Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: potential involvement of G protein and phosphatidylinositol 3-kinase (PI3) kinase. Biochem Pharmacol 2001;61:779-786.
22. Jain N, Patil CS, Singh A, Kulkami SK: Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine. Pharmacology 2003;67:150-156.
23. Xu JY, Hill KP, Bidlack JM: The nitric oxide cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance. J Pharmacol Exp Ther 1998;284:196-201.
24. Heagy W, Teng E, Lopez P, Finberg RW: Enkephalin receptors and receptor-mediated signal transduction in cultured human lymphocytes. Cell Immunol 1999;191:34-48.
25. Martin-Kleiner I, Gabrilovac J: Increase of intracellular cAMP level in human peripheral blood mononuclear cells by Met-enkephalin. Acta Pharm 1997;47:9-14.
26. Sorensen AN, Claesson MH: Effect of the opioid methionine enkephalinamide on signal transduction in human T-lymphocytes. Life Sci 1998;62:1251-1259.
27. Martin-Kleiner I, Gabrilovac J: The effect of delta-opioid agonists on intracellular calcium level in MOLT-4 T-cell line. Int J Immunopathol Pharmacol 1999;12:113-119.
28. Li PF, Hao YS, Zhang FX, Liu XH, Liu Sl, Li G: Signaling pathway involved in methionine enkephalin-promoted survival of lymphocytes infected by simian immunodeficiency virus in the early stage in vitro. Int Immunopharmacol 2004;4:79-90.
29. Liu HH, Huang DA, Yang FY, Hao YS, Du GG, Li PF, Li G: A new cytokine: the possible effect pathway of methionine enkephalin. World J Gastroenterol 2003;9:169-173.
30. Shahabi NA, Daaka Y, McAllen K, Sharp BM: Delta opioid receptors expressed by stably transfected Jurkat cells signal through the MAP kinase pathway in a Ras-independent manner. J Neuroimmunol 1999;94:48-57.
31. Shahabi NA, McAllen K, Sharp BM: Phosphorylation of activating transcription factor in murine splenocytes through delta opioid receptors. Cell Immunol 2003;221:122-127.
32. Hedin KE, Bell MP, Kalli RK, Huntoon CJ, Sharp BM, McKean DJ: Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. J Immunol 1997;159:5431-5440.
33. Sun P, Loh HH: Transcriptional regulation of mouse delta-opioid receptor gene - role of Ikaros in the stimulated transcription of mouse delta-opioid receptor gene in activated T cells. J Biol Chem 2002;277:12854-12860.
34. Sun P, Loh HH: Transcript ional regulation of mouse delta-opioid receptor gene. Ikaros-2 and upstream stimulatory factor synergize in transactivating mouse delta-opioid receptor gene in T cells. J Biol Chem 2003;278:2304-2308.
35. Marotti T, Balog T, Mazuran R, Ročić B: The role of cytokines in MET-enkephalin-modulated nitric oxide release. Neuropeptides 1998;32:57-62.
36. Balog T, Marotti T, Musani V, Sobočanec V, Šverko, V: The effect of methionine-enkephalin on nitric oxide release in mice is age and gender related. Pharm Res 2001;44:287-292.
37. Vujić V, Stanojević S, Dimitrijević M: Methionine-enkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophages: interaction of mu, delta and kappa opioid receptors. Neuroimmunomodulation 2004;11:392-403.
38. Gomez-Flores R, Rice KC, Zhang XY, Weber RJ: Increased tumor necrosis factor-alpha and nitric oxide production by rat macrophages following in vitro stimulation and intravenous administration of the delta-opioid agonists SNC 80. Life Sci 2001;68:2675-2684.
39. Nozaki-Taguchi N, Yamamoto T: Involvement of nitric oxide in peripheral antinociception mediated by kappa and delta-opioid receptors. Anesth Analg 1998;87:388-393.
40. Joseph DB, Bidlack JM: The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure. J Pharmacol Exp Ther 1995;272:970-976.
41. Martin-Kleiner I, Bidlack JM: Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of kappa opioid receptor without desensitization of adenylyl cyclase activity. Int Immunopharmacol 2001;1:13-20.
42. Martin-Kleiner I, Gabrilovac J: The kappa-opioid agonist U-69593 affects intracellular calcium level in R1.1 mouse thymoma cell line. Int Immunopharmacol 2002;2:975-980.
43. Martin-Kleiner I, Bidlack JM: The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell line. Int J Immunopharmacol 1999;21:133-140.
44. Kam AY, Chan AS, Wong YH: Kappa-opioid receptor signals through Src and focal adhesion kinase to stimulate c-Jun N-terminal kinases in transfected COS-7 cells and human monocytic THP-1 cells. J Pharmacol Exp Ther 2004;310:301-310.
45. Li JH, Park SW, Loh HH, Wei LN: Induction of mouse kappa-opioid receptor gene by retinoic acid in P19 cells. J Biol Chem 2002;277:39967-39972.
46. Gabrilovac J, Balog T, Andreis A: Dynorphin-A (1-17) decreases nitric oxide release and cytotoxicity induced with lipopolysaccharide plus interferon-gamma in murine macrophage cell line J774. Biomed Pharmacother 2003;57:351-358.
47. Chuang LF, Killam KF, Chuang RY: Induction and activation of mitogen-activated protein kinases in human lymphocytes as one of the signaling pathways of the immunomodulatory effect of morphine sulphate. J Biol Chem 1997;272:26815-26817.
48. Singhal PC, Bhaskaran M, Patel J, Patel K, Kasinath BS, Duraisamy S, Franki N, Reddy K, Kapasi AA: Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine induced macrophage apoptosis. J Immunol 2002;168:4025-4033.
49. Rozenfeld-Granot G, Toren A, Amariglio N, Nagler A, Rosenthal E, Biniaminov M, Brok-Simoni F, Rechavi G: MAP kinase activation by mu-opioid receptor in cord blood CD34+CD38- cells. Exp Hematol 2002;30:473-480.
50. Wang JH, Barke RA, Charboneau RG, Loh HH, Roy S: Morphin negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J Biol Chem 2003;278:37622-37631.
51. Roy S, Chapin RB, Cain KJ, Charboneau RG, Ramakrishnan S, Barke RA: Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes. Cell Immunol 1997;179:1-9.
52. Roy S, Cain KJ, Chapin RB, Charboneau RG, Barke RA: Morphine modulates NF kappa B activation in macrophages. Biochem Biophys Res Commun 1998;245:392-396.
53. Roy S, Wang JH, Gupta S, Charboneau R, Loh HH, Barke RA: Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. J Neuroimmunol 2004;147:78-81.
54. Suzuki S, Chuang LF, Doi H, Chuang RY: Identification of opioid regulated genes in human lymphocytic cells by differential display: upregulation of Kruppel-like factor 7 by morphine. Exp Cell Res 2003;291:340-351.
55. Kraus J, Borner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, Konig W, Hollt V: Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 2001;276:43901-43908.
56. Kraus J, Borner C, Giannini E, Hollt V: The role of nuclear factor kappa B in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol 2003;64:876-884.
57. Schneider GM, Lysle DT: Role of central mu-opioid receptors in the modulation of nitric oxide production by splenocytes. J Neuroimmunol 1998;89:150-159.
58. Wang JH, Charboneau R, Balasubramanian S, Barke RA, Loh HH, Roy S: Morphine modulates lymph node-derived T lymphocyte function: role of caspase-3, -8, and nitric oxide. J Leukoc Biol 2001;70:527-536.